HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
414.03
+0.67 (0.16%)
At close: Aug 10, 2026, 4:00 PM EDT
413.02
-1.01 (-0.24%)
Pre-market: Aug 11, 2026, 8:14 AM EDT
HCA Healthcare Stock Forecast
Stock Price Forecast
According to 25 analysts polled by S&P Global, HCA Healthcare stock has a consensus rating of "Buy" and an average price target of $454.57. The average 1-year stock price forecast is 9.79% higher than the current stock price, while the lowest is $380 (-8.22%) and the highest is $579 (+39.84%).
Price Target: $454.57 (+9.79%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HCA Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 13 | 13 | 13 | 13 | 13 | 13 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 9 | 9 | 9 | 9 | 10 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 25 | 25 | 25 | 25 | 25 | 25 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Hold Reiterates $400 → $425 | Hold | Reiterates | $400 → $425 | +2.65% | Aug 10, 2026 |
Unknown Analyst Argus Research No rating | Argus Research | Buy Maintains $500 | Buy | Maintains | $500 | +20.76% | Aug 7, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $495 | Buy | Reiterates | $495 | +19.56% | Aug 5, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $369 → $381 | Hold | Reiterates | $369 → $381 | -7.98% | Aug 3, 2026 |
| Jefferies | Jefferies | Buy Maintains $450 | Buy | Maintains | $450 | +8.69% | Jul 29, 2026 |
Financial Forecast
Revenue This Year
78.52B
from 75.60B
Increased by 3.86%
Revenue Next Year
81.63B
from 78.52B
Increased by 3.97%
EPS This Year
29.56
from 28.21
Increased by 4.78%
EPS Next Year
32.16
from 29.56
Increased by 8.80%
EPS and Forward PE are based on non-GAAP adjusted numbers.